| Literature DB >> 15837333 |
Steven K Laughlin1, Michael P Clark, Jane F Djung, Adam Golebiowski, Todd A Brugel, Mark Sabat, Roger G Bookland, Matthew J Laufersweiler, John C VanRens, Jennifer A Townes, Biswanath De, Lily C Hsieh, Susan C Xu, Richard L Walter, Marlene J Mekel, Michael J Janusz.
Abstract
4-Aryl-3-pyridyl and 4-aryl-3-pyrimidinyl based tumor necrosis factor-alpha (TNF-alpha) inhibitors, which contain a novel isoxazolone five-membered heterocyclic core are described. Many showed sub-micromolar activity against lipopolysaccharide-induced TNF-alpha production.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15837333 DOI: 10.1016/j.bmcl.2005.02.066
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823